Skip Nav Destination
Issues
15 September 2008
-
Cover Image
Cover Image
Monocytes/macrophages are the cellular carrier of Chlamydiophila psittaci infection in lymphomas. Other cellular elements, including neoplastic B cells and nonneoplastic T cells, endothelia and stromal cells, are not Chlamydia's targets. This infection is usually correlated with marginal zone B-cell lymphomas of ocular adnexa; however, other lymphomas with different histotypes and arising in extra-ocular adnexal sites, in particular represented by air-exposed anatomic locations, may be associated with this infection. For further details, please see Ponzoni and co-workers on page 5794 in this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
CCR Translations
CCR Practice of Translational Oncology
Molecular Pathways
CCR Special Focus
Human Cancer Biology
Multiple Primary Sporadic Gastrointestinal Stromal Tumors in the Adult: An Underestimated Entity
Daniela Gasparotto; Sabrina Rossi; Italo Bearzi; Claudio Doglioni; Alessandra Marzotto; Jason L. Hornick; Alessandra Grizzo; Chiara Sartor; Alessandra Mandolesi; Raf Sciot; Maria Debiec-Rychter; Angelo Paolo Dei Tos; Roberta Maestro
Cancer Therapy: Preclinical
Tris (Dibenzylideneacetone) Dipalladium, a N-Myristoyltransferase-1 Inhibitor, Is Effective against Melanoma Growth In vitro and In vivo
Sulochana S. Bhandarkar; Jacqueline Bromberg; Carol Carrillo; Ponniah Selvakumar; Rajendra K. Sharma; Betsy N. Perry; Baskaran Govindarajan; Levi Fried; Allie Sohn; Kalpana Reddy; Jack L. Arbiser
Activity of Dasatinib, a Dual SRC/ABL Kinase Inhibitor, and IPI-504, a Heat Shock Protein 90 Inhibitor, against Gastrointestinal Stromal Tumor–Associated PDGFRAD842V Mutation
Barbara Dewaele; Bartosz Wasag; Jan Cools; Raf Sciot; Hans Prenen; Peter Vandenberghe; Agnieszka Wozniak; Patrick Schöffski; Peter Marynen; Maria Debiec-Rychter
A Novel Inhibitor of Signal Transducers And Activators Of Transcription 3 Activation Is Efficacious Against Established Central Nervous System Melanoma and Inhibits Regulatory T Cells
Ling-Yuan Kong; Mohamed K. Abou-Ghazal; Jun Wei; Arup Chakraborty; Wei Sun; Wei Qiao; Gregory N. Fuller; Izabela Fokt; Elizabeth A. Grimm; Robert J. Schmittling; Gary E. Archer, Jr.; John H. Sampson; Waldemar Priebe; Amy B. Heimberger
Imaging, Diagnosis, Prognosis
Chlamydia Infection and Lymphomas: Association Beyond Ocular Adnexal Lymphomas Highlighted by Multiple Detection Methods
Maurilio Ponzoni; Andrés J.M. Ferreri; Massimo Guidoboni; Antonia A. Lettini; Maria Giulia Cangi; Elisa Pasini; Luciano Sacchi; Lorenza Pecciarini; Stefano Grassi; Elena Dal Cin; Rosalba Stefano; Simone Magnino; Riccardo Dolcetti; Claudio Doglioni
Association of Prostate Cancer Risk Variants with Clinicopathologic Characteristics of the Disease
Jianfeng Xu; Sarah D. Isaacs; Jielin Sun; Ge Li; Kathleen E. Wiley; Yi Zhu; Fang-Chi Hsu; Fredrik Wiklund; Aubrey R. Turner; Tamara S. Adams; Wennuan Liu; Bruce J. Trock; Alan W. Partin; Baoli Chang; Patrick C. Walsh; Henrik Grönberg; William Isaacs; Siqun Zheng
The Effects of Common Genetic Variants in Oncogenes on Ovarian Cancer Survival
Lydia Quaye; Simon A. Gayther; Susan J. Ramus; Richard A. Di Cioccio; Valerie McGuire; Estrid Hogdall; Claus Hogdall; Jan Blaakr; Douglas F. Easton; Bruce A.J. Ponder; Ian Jacobs; Susanne Kruger Kjaer; Alice S. Whittemore; Celeste Leigh Pearce; Paul D.P. Pharoah; Honglin Song
Prognostic Effect of Epithelial Cell Adhesion Molecule Overexpression in Untreated Node-Negative Breast Cancer
Marcus Schmidt; Dirk Hasenclever; Mitra Schaeffer; Daniel Boehm; Cristina Cotarelo; Eric Steiner; Antje Lebrecht; Wulf Siggelkow; Wolfgang Weikel; Ilka Schiffer-Petry; Susanne Gebhard; Henryk Pilch; Mathias Gehrmann; Hans-Anton Lehr; Heinz Koelbl; Jan G. Hengstler; Martin Schuler
Cancer Therapy: Clinical
Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Neutropenia during Phase I Development of Liposome-Entrapped Paclitaxel
Gerald J. Fetterly; Thaddeus H. Grasela; Jeffrey W. Sherman; Jeanne L. Dul; Amy Grahn; Diane Lecomte; Jill Fiedler-Kelly; Nevena Damjanov; Mayer Fishman; Michael P. Kane; Eric H. Rubin; Antoinette R. Tan
Cytochrome P450 2D6 and Homeobox 13/Interleukin-17B Receptor: Combining Inherited and Tumor Gene Markers for Prediction of Tamoxifen Resistance
Matthew P. Goetz; Vera J. Suman; Fergus J. Couch; Matthew M. Ames; James M. Rae; Mark G. Erlander; Xiao-Jun Ma; Dennis C. Sgroi; Carol A. Reynolds; Wilma L. Lingle; Richard M. Weinshilboum; David A. Flockhart; Zeruesenay Desta; Edith A. Perez; James N. Ingle
Clinical Usefulness of EGFR Gene Copy Number as a Predictive Marker in Colorectal Cancer Patients Treated with Cetuximab: A Fluorescent In situ Hybridization Study
Nicola Personeni; Steffen Fieuws; Hubert Piessevaux; Gert De Hertogh; Jef De Schutter; Bart Biesmans; Wendy De Roock; An Capoen; Maria Debiec-Rychter; Jean-Luc Van Laethem; Marc Peeters; Yves Humblet; Eric Van Cutsem; Sabine Tejpar
Sunitinib-Induced Myeloid Lineage Redistribution in Renal Cell Cancer Patients: CD1c+ Dendritic Cell Frequency Predicts Progression-Free Survival
Hester van Cruijsen; Astrid A.M. van der Veldt; Laura Vroling; Dinja Oosterhoff; Henk J. Broxterman; Rik J. Scheper; Giuseppe Giaccone; John B.A.G. Haanen; Alfons J.M. van den Eertwegh; Epie Boven; Klaas Hoekman; Tanja D. de Gruijl
Randomized Study of Intravenous versus Subcutaneous Interleukin-2, and IFNα in Patients with Good Prognosis Metastatic Renal Cancer
Sylvie Négrier; David Perol; Alain Ravaud; Jacques O. Bay; Stéphane Oudard; Sylvie Chabaud; Pierre Fargeot; Remy Delva; Gael Deplanque; Gwenaelle Gravis; Bernard Escudier; for the French Immunotherapy Group
Cancer Prevention and Susceptibility
Familial Non-VHL Clear Cell (Conventional) Renal Cell Carcinoma: Clinical Features, Segregation Analysis, and Mutation Analysis of FLCN
Emma R. Woodward; Christopher Ricketts; Pip Killick; Sophie Gad; M.R. Morris; Fred Kavalier; Shirley V. Hodgson; Sophie Giraud; Brigitte Bressac-de Paillerets; Cyril Chapman; Bernard Escudier; Farida Latif; Stéphane Richard; Eamonn R. Maher
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds